Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	46.24	32.88	22.48
Graham Fair Price	-18.11	999.11	1219.99
PEG	174.61	-0.19	0.07
Price/Book	-3.45	0.66	0.69
Price/Cash Flow	28.15	14.14	11.04
Prices/Earnings	46.97	6.53	4.45
Price/Sales	6.36	0.65	0.61
Price/FCF	28.15	14.14	11.04
Naive Interpretation	member

01 - Valuation · Somewhat Positive

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-18.73	0.06	0.07
Operating Margin	-43.32	0.03	0.05
ROA	-32.97	< 0.005	0.01
ROE	0.04	0.03	-34.30
ROIC	0.02	0.01	-44.19
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.02	-0.04	49.05
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	1.42	-0.48	-66.27
EPS QOQ	0.63	-0.34	-46.48
FCF QOQ	0.87	-0.24	-72.61
Revenue QOQ	0.04	-0.08	103.91
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	52.58	56.91	8.22
Days Sales Outstanding (DSO)	69.80	69.01	-1.12
Inventory Turnover	1.71	1.58	-7.60
Debt/Capitalization	0.56	0.55	-1.35
Quick Ratio	0.65	0.62	-5.27
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	1307.05	1320.61	1.04
Cash	194.67	201.42	3.47
Capex	-5.46	-64.45	-1080.76
Free Cash Flow	81.55	62.08	-23.88
Revenue	1483.78	1361.00	-8.27
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.06	1.05	-0.94
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	14.17	20.60	45.41
Naive Interpretation	Member

06 - Financial Health · Bad

Rating